Anuoluwa Eunice Oyetoran, MD
Hematology & Oncology Physician · Royal Oak, MI
Anuoluwa Eunice Oyetoran, MD is a hematology & oncology physician with a practice address in Royal Oak, Michigan, and NPI 1184358699, issued on Jul 11, 2022. Check the license (Michigan 4351055436, as entered in NPPES) on the Michigan Board of Medicine (LARA); the Medicare figures below come from public CMS files.
- Name
- Anuoluwa Eunice Oyetoran
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License number
- 4351055436 MI
Self-reported in NPPES; status is on the state search - Practice location
- 3601 W 13 Mile RD, Royal Oak, MI 48073
- Phone
- (248) 551-3850
- Enumerated
- Jul 11, 2022
- Record last updated
- Jul 2, 2025
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 340 in Michigan → Look up another NPI →
Also registered at 3601 W 13 Mile RD
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Mary Ann Abbass, C.N.M.Advanced Practice Midwife1003245622
- Mohammad Abdulla, DODiagnostic Radiology Physician1093338188
- Rasheed Abdullah, MDDiagnostic Radiology Physician1023851847
- Darian Aboubakare, MDSleep Medicine (Internal Medicine) Physician1558941674
- Farah Aboufakhr, MDAnesthesiology Physician1093409260
- Mohamad Aboumourad, DOInternal Medicine Physician1669225637
Verify Anuoluwa Eunice Oyetoran in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMichigan Board of Medicine (LARA)
Search for license 4351055436Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
89% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
96 Medicare Part D claims for 34 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 14% of claims.
Most prescribed
- Atorvastatin Calcium14 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $174.53
3 payments; by number, the most common kind was food and beverage; the largest payer was Iti, Inc. (d/b/a Intra-Cellular Therapies, Inc.). The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Anuoluwa Eunice Oyetoran among 340 hematology & oncology physician records in Michigan
Anuoluwa Eunice Oyetoran, MD is one of 340 hematology & oncology physician records with a practice address in Michigan. 82% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2022, is newer than 95% of them.
- NPI issued2022 · 95% of these records are older, 4% newer
- In a Medicare fileYes · 82% of these records are
- In the CMS Doctors and Clinicians fileNo · 61% of these records are
- Record last updated2025 · 52% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Michigan practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Michigan
There are 340 hematology & oncology physician records in Michigan.
All 340 in Michigan → Every provider in Royal Oak → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Samer Ballouz, M.D.Royal Oak, MI 480731528068020
- Janet Chapman, M.D.Royal Oak, MI 480731972723385
- Matthew Cotant, M.D.Royal Oak, MI 480731003930215
- Marianne Huben, D.O.Royal Oak, MI 480731871552414
- Mohammed Ibrahim, MDRoyal Oak, MI 480731891701082
- Deepa Jagtap, M.D.Royal Oak, MI 480731629190095
- Ishmael Jaiyesimi, D.O.Royal Oak, MI 480731538128178
- Manolo Magno, M.D.Royal Oak, MI 480731659371151
Common questions
What is Anuoluwa Eunice Oyetoran, MD's NPI number?
Anuoluwa Eunice Oyetoran, MD's National Provider Identifier (NPI) is 1184358699, issued on Jul 11, 2022. An NPI identifies a provider in billing; it is not a license.
Where is Anuoluwa Eunice Oyetoran, MD located?
The NPPES record lists a practice address at 3601 W 13 Mile RD, Royal Oak, MI, 48073. Phone: (248) 551-3850. Providers update this record themselves, so call before visiting.
How can I verify Anuoluwa Eunice Oyetoran, MD's license?
NPPES lists Michigan license number 4351055436, as entered by the provider. Search the Michigan Board of Medicine (LARA) at https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?isLicensee=Y&TabName=APO. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Anuoluwa Eunice Oyetoran, MD prescribe under Medicare Part D?
In 2024, Anuoluwa Eunice Oyetoran, MD had 96 Medicare Part D claims for 34 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.